Skip to content

Complications of the Cephalic Route in Implantable Site Placement in Children

Complications of the Cephalic Route in Implantable Site Placement in Children

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06644885
Acronym
SitePedia
Enrollment
426
Registered
2024-10-16
Start date
2024-12-15
Completion date
2025-04-15
Last updated
2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Device Safety, Surgical Complications

Brief summary

Totally implantable venous access devices (TIVADs) offer long-term central venous access for children requiring intravenous treatments. Their use is recommended in infants (31 days - 1 year old) for \>31 days of non-peripherally compatible therapy, and in children and adolescents (\>1 year old) for any intravenous therapy lasting more than 31 days. Indications include chemotherapy administration and chronic disease management, avoiding repeated peripheral venous punctures and causing less interference with the activities of the patients. There are several methods for TIVAD placement, but the optimal evidence-based method remains unclear . The two main approaches for TIVAD placement are closed cannulation of a vein, followed by insertion of the catheter in Seldinger technique, and the surgical insertion of the catheter into a vein through an open cut-down technique 5-7. Different location of insertion are possible: by closed cannulation, the catheter is usually placed in subclavian vein, internal jugular vein, and brachiocephalic vein; by open cut-down it can be placed in external jugular vein, axillary vein, or cephalic vein. Thanks to progress in medical and surgical care, children are nowadays surviving previously fatal illnesses, but with the need of long-term treatments. For this reason, it's essential to preserve their vessel health. With this objective, in the CHU of Angers, physicians prefer trying first the cephalic vein cutdown for TIVAD positioning in children, reserving the use of other venous accesses in case of failure of this procedure or the need for multiple devices implantations. To date, few reports have been published about cephalic vein cutdown in children. It is a common opinion that this technique can't be successfully performed in patients under a certain limit of weight or age. In this context, the investigators conducted a retrospective single-centre study to analyse the results of cephalic vein cutdown in children. The primary aim was to describe the feasibility of this technique in paediatric population and identify the risks factors associated with its failure. In addition, this study describes indications, outcomes, and complications of TIVAD implantation.

Interventions

PROCEDURETIVAD implantation complications

Follow up and post operative outcome of patients with devices implantation

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* All patients under 18 years who underwent TIVAD implantation between 2012 and 2022. * Patients for whom cephalic vein cutdown was the first attempted surgical technique for device placement.

Exclusion criteria

* Patients who previously had a central venous access

Design outcomes

Primary

MeasureTime frameDescription
Characteristics of the study group1 yearRisk factors for cephalic vein cutdown failure for TIVAD positioning

Secondary

MeasureTime frameDescription
cephalic vein cutdown1 yearPost-operative complications of cephalic vein cutdown
Post-operative complications1 year
TIVAD removal1 year

Contacts

Primary ContactAurora MARIANI
Aurora.Mariani@chu-angers.fr0241353637

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026